The CRE Insider
Searching for Solutions to Boston’s Lab Glut
Developers have seen the bottom fall out of the Boston lab real estate market. But construction costs over $1,000 per square foot put most non-biotech tenants out of reach.
State Should Target Western Mass. for Biomanufacturing Push
Massachusetts can be a winner in the federal government’s push to bring biomanufacturing back to the United States – if it plays its cards right.
Signs of Life in Boston Biotech CRE
Little tiny green shoots are poking up here and there, with leasing activity running well ahead of 2024 totals and the pace of vacancy growth slowing down.
Beacon Hill Must Keep Biotech’s Flywheel Turning
To maintain Massachusetts’ leadership in global drug development, we cannot allow uncertainty and alarm bells coming from its biotech sector to paralyze us.
Woods Hole Project Illustrates Coastal Permitting Challenges
The deepwater port on Cape Cod has hosted research vessels for nearly 100 years. But replacing its main dock took years of permitting and consensus-building.
What’s Driving Transaction Activity in 2025
With vacancy rates elevated, demand softening and pricing still under pressure, the relative appeal of ownership has only grown. And it’s leading driving some major transactions.
How New Projects Are Responding to Climate Concerns in Boston
Like other waterfront cities, Boston faces existential risk from climate change – not just rising sea levels, but also sudden rainstorms and extreme temperatures.
This Week’s Newspaper
